Fundraising Fox

Stoke Therapeutics

NASDAQ: STOK

Bedford, US · Founded 2014 · 1 known investors

Biotech

Founders & leadership

HN
Huw NashNamed on SEC filing
AK
Adrian KrainerNamed on SEC filing
IA
Isabel AznarezNamed on SEC filing

Investors · 1

5AM VenturesreportedBoston · $100K – $4Mvia Arthur Tzianabos · board

Reported raises · per SEC filings

Form D private placements

$90.8M disclosed across 2 rounds · 2014–2018

▶$90MraisedNov 2018 · 14 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Barry TichoExecutive Officer
  • Charles R. AllersonExecutive Officer
  • Gene LiauExecutive Officer
  • Adrian KrainerExecutive Officer, Director, Promoter
  • Edward M. KayeExecutive Officer, Director
  • Seth L. HarrisonDirector
  • Samuel W. HallDirector
  • Meena MeenaExecutive Officer
  • Arthur A. LevinDirector
  • Arthur TzianabosDirector
  • Isabel AznarezExecutive Officer, Promoter
  • Huw NashExecutive Officer
Offering amount
$90M
Amount sold
$90M
First sale
Oct 2018
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$850KraisedNov 2014 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Huw NashExecutive Officer
  • Adrian KrainerExecutive Officer, Director, Promoter
  • Isabel AznarezExecutive Officer, Director, Promoter
Offering amount
$850K
Amount sold
$850K
First sale
Nov 2014
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Stoke Therapeutics, Inc. (STOK) Investor Outlook: A Promising 43.5% Upside In Biotech's Genetic Revolutiondirectorstalkinterviews.com · Aug 2026What Is Stoke Therapeutics (STOK) Signaling With A 2 Million Share Shelf Filing?finance.yahoo.com · Aug 2026Stoke Therapeutics (STOK) Stock Climbs As Cash Burn Meets Dravet Momentum - Simply Wall St Newssimplywall.st · Aug 2026Stoke Therapeutics Expands ATM Equity Program for Funding - The Globe and Mailtheglobeandmail.com · Aug 2026Stoke Therapeutics earnings missed by $0.16, revenue topped estimates By Investing.cominvesting.com · Aug 2026

Frequently asked questions

Who are Stoke Therapeutics's investors?
Stoke Therapeutics's investors include 5AM Ventures.
How much funding has Stoke Therapeutics raised?
Stoke Therapeutics has disclosed $90.8M raised across 2 rounds.
Where is Stoke Therapeutics headquartered?
Stoke Therapeutics is headquartered in Bedford, US.